Position in FBRX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$10,360,000
-$548,000 QoQ
Shares Held
400,000
0.0% QoQ
Ownership
2.88%
of shares outstanding
% of Portfolio
5.34%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2024
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in FBRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Cable Car Capital, LP holds $48,389,745 across 11 Biotechnology names. FBRX ranks #2 (21.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABEO |
Abeona Therapeutics Inc.
|
3,007,329 | $13,472,833 | |
| 2 | FBRX |
Forte Biosciences, Inc.
This page
|
400,000 | $10,360,000 | |
| 3 | ORKA |
Oruka Therapeutics, Inc.
|
200,000 | $9,810,000 | |
| 4 | ACOG |
Alpha Cognition Inc.
|
1,382,339 | $7,589,041 | |
| 5 | IMA |
ImageneBio, Inc.
|
754,749 | $3,773,745 | |
| 6 | BCTX |
BriaCell Therapeutics Corp.
|
216,821 | $908,479 | |
| 7 | MAIA |
MAIA Biotechnology, Inc.
|
648,503 | $907,904 | |
| 8 | KTTA |
Pasithea Therapeutics Corp.
|
1,206,379 | $895,133 |
All Filings in FBRX
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $10,360,000 | 400,000 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $10,908,000 | 400,000 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $7,500,000 | 500,000 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $6,465,000 | 500,000 | Shares | Sole | 2025-08-15 | |
| 2025-03-31 | $1,704,127 | 219,604 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $4,987,206 | 219,604 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $454,349 | 81,279 | Shares | Sole | 2024-11-14 | |
| No filing history on record for this holder in this stock. | ||||||